Maintenance

Product information
Opdivo (nivolumab)
Yervoy (ipilimumab)
Opdualag (nivolumab + relatllimab)

Melanoma

Melanoma Highlights

MET Opdivo + Yervoy

Metastatic Opdualag

Adjuvant Opdivo

Melanoma Materials

Genitourinary cancers

Genitourinary Highlights

Genitourinary Materials

Genitourinary Case Studies

Gastrointestinal Cancers

Gastro-oesophageal Highlights

Gastro-oesophageal Materials

Gastrointestinal Case Studies

Thoracic cancers

Thoracic Highlights

Early Stage NSCLC

Metastatic NSCLC

Thoracic Materials

Thoracic Case Studies

Met-nsclc-ros1-postive

Patient Resources

PBS Codes & Dosing Information

irAR Management

Melanoma Treatment Sequencing Tool

Materials Catalogue

EVIQ

My Profile Log out

This page is currently undergoing maintenance and is temporarily unavailable. We apologize for the inconvenience and appreciate your patience. Please check back again soon.

foot note heading

Modern Slavery Statement

© 2026 Bristol-Myers Squibb.

Bristol-Myers Squibb Australia Pty Ltd, ABN 33 004 333 322, 4 Nexus Court, Mulgrave, VIC 3170.